House
GuidelinesCalculatorsPricingBlog
Ask House ↗
Guidelines↗Calculators↗Pricing↗Blog↗
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House
Back to guidelines
Ophthalmology

Bacterial keratitis

AAO · 2024 edition / updateSource checked 29 October 2026
Read the source publication
House clinical summary

Scope

The AAO pathway treats bacterial keratitis as a potentially sight-threatening infection requiring prompt ophthalmic assessment, severity-directed microbiology and intensive topical antibiotics. Treatment changes depend on the clinical response, with carefully restricted steroid use and close follow-up for central, deep or progressive disease.

Written by House with AI assistance · AI-assisted source check 29 October 2026.

This is House’s summary of the cited guidance. The source check is not an independent clinician review. Open the publication for complete recommendations, exceptions, evidence grades and later amendments.

Recognize risk and assess the threatened eye

  • Arrange prompt ophthalmic evaluation for suspected keratitis. Rapid tissue loss, corneal perforation and endophthalmitis can threaten vision; diagnostic uncertainty or severe or refractory disease warrants corneal expertise. [1]
  • Record symptom onset, contact-lens use and hygiene, overnight or water exposure, trauma, prior surgery or infection, immune status, recent medications and allergies. [1]
  • Document baseline visual acuity and examine with a slit lamp, assessing epithelial defect, infiltrate location and size, depth, thinning or perforation, and anterior-chamber inflammation. Examine the other eye for clues to the cause. [1]

Culture the higher-risk presentations

  • Small peripheral ulcers without stromal melting may be treated empirically. Obtain smears and cultures before antimicrobial treatment for central large infiltrates, significant stromal involvement or melting, anterior-chamber inflammation, prior corneal surgery, atypical features or multiple infiltrates. [1]
  • Culture is also useful after organic-matter trauma, water-exposed contact-lens wear, chronic infection or poor response to broad-spectrum treatment. A hypopyon alone does not justify an aqueous or vitreous tap: reserve that for high suspicion of endophthalmitis. [1]
  • Sample the infected cornea and promptly inoculate appropriate media or use transport media. Contact lenses, cases and solution can provide additional culture information. Persistent disease with negative cultures may require repeat sampling, special media or corneal biopsy. [1]
  • Reconsider fungal, Acanthamoeba, viral and noninfectious causes when the presentation or response is atypical. Ring infiltrates can occur in fungal and Acanthamoeba disease; marked pain and radial keratoneuritis particularly suggest Acanthamoeba. [1]

Match intensity to disease severity

  • Topical antibiotic drops are the preferred treatment in most bacterial keratitis. Consider fortified topical therapy for large or visually significant infiltrates, especially with hypopyon; resistance and clinical response guide the antibiotic choice. [1]
  • For central or severe disease, such as deep stromal infection or an infiltrate larger than 2 mm with extensive suppuration, use an intensive loading schedule, for example every 5–15 minutes followed by hourly applications. The selected agent and formulation require specialist prescribing. [1]
  • Cycloplegics may reduce anterior-segment inflammatory pain and synechiae. Systemic antibiotics are rarely required, but may be considered for adjacent-tissue extension or threatened perforation; systemic treatment is necessary for gonococcal keratitis. [1]
  • Review severe cases daily initially until stabilization or improvement. Admission may be necessary for severe or sight-threatening disease, severe pain or inability to reliably administer the required drops. [1]

Restrict steroid use and monitor closely

  • Corticosteroids may be considered after 48 hours of antibiotic therapy when the organism is identified and/or the infection has responded. Avoid them when Acanthamoeba, Nocardia or fungus is suspected. [1]
  • For an infiltrate compromising the central cornea, topical corticosteroids may be added after at least 2–3 days of progressive improvement on antibiotics, typically after pathogen identification and exclusion of fungal infection. Avoid steroids when Acanthamoeba, Nocardia or fungus is suspected. Continue adequate antibacterial treatment and close follow-up. [1]
  • After starting topical steroids, monitor intraocular pressure and re-examine within 1–2 days. Discuss cataract and glaucoma risks with prolonged use. At presentation, an existing topical steroid regimen should be reduced or stopped until infection is controlled, recognizing that withdrawal can temporarily increase inflammation. [1]

Reassess response, protect the cornea and prevent recurrence

  • Generally modify the initial regimen if improvement or stabilization has not occurred within 48 hours. Pseudomonas and other gram-negative disease can show more inflammation during the first 24–48 hours despite appropriate treatment, so judge the overall course. [1]
  • Taper topical antibiotics according to clinical response and initial severity, avoiding subtherapeutic dosing. Prolonged treatment can itself cause toxicity and melting; poor response, especially with negative cultures, calls for diagnostic reassessment, repeat culture and/or biopsy. [1]
  • Extremely thin cornea, threatened or established perforation, progressive unresponsive infection or endophthalmitis requires additional specialist treatment. Surgical tissue should be sent for pathological and microbiological examination. [1]
  • For corneal abrasion in a contact-lens wearer, prescribe topical antibiotic prophylaxis and avoid patching or a therapeutic contact lens early on. A broad-spectrum topical antibiotic is also recommended after traumatic abrasion. [1]
  • Explain strict adherence and the risk of permanent visual loss. Before resuming contact lenses, reassess fit, lens choice, hygiene and wearing schedule, particularly overnight wear; address the timing with the treating ophthalmologist. [1]

Limitations and use

  • This selected clinical summary does not reproduce the antibiotic concentration table, compounding instructions, organism-specific rescue regimens or surgical techniques. Use the complete guideline, local susceptibility information and ophthalmic prescribing expertise.
  • These recommendations concern bacterial keratitis. Fungal, Acanthamoeba and other nonbacterial infections require their own diagnostic and treatment pathways; steroid eligibility must not be inferred from a presumed bacterial label alone.

This summary is selective and does not reproduce every recommendation. Apply the source’s population, setting and eligibility criteria, together with clinical judgement and local policy.

Summary sources

  1. 1
    Bacterial keratitis

    Selected recommendation material consulted

Preferred Practice Pattern guideline

Publication details

Issuing organisation
AAO
First published
13 February 2024
Resource type
Preferred Practice Pattern guideline · House clinical summary

The source check confirms publication details and the linked edition. It does not certify every recommendation or its suitability for an individual patient. Publisher access conditions may apply.

On this page

  • Scope
  • Recognize risk and assess the threatened eye
  • Culture the higher-risk presentations
  • Match intensity to disease severity
  • Restrict steroid use and monitor closely
  • Reassess response, protect the cornea and prevent recurrence
  • Limitations and use
  • Summary sources
  • Publication details
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House